Skip to main content

GuidelinesBy device type2026.10.15

Wound Dressing Classification in Korea: Start with Purpose, Contact and Claims

Foam, film and hydrogel names do not determine a dressing's Korean class or evidence requirements. Define the wound, contact conditions, action and claimed effects before selecting a regulatory category.

Begin with which wound the product is used on, how it acts and what it claims to achieve. The same material can raise different classification and evidence questions when that description changes.

1. Write one clear intended-use statement

Do not collapse wound management, healing promotion, protection, absorption and scar management into one meaning. Establish what the product is designed to do, its wound types and stages, and its limitations. Directly translating a broad promotional statement can unintentionally expand the proposed scope.

MFDS's integrated dressing guidance addresses definitions, classification, submission evidence and clinical evidence considerations. Compare each product with the applicable item definition; wound dressing is not one fixed class. Where the boundary with another product category is uncertain, first establish status using composition and mechanism information.

2. Organize four classification inputs

This table organizes manufacturer answers; it does not automatically assign a class. Use wound descriptions supported by manufacturer instructions and evidence.

Question Evidence to obtain Common confusion
Where is it used? Wounds, sites, treatment stages Mixing intact-skin protection with wound use
How does it act? Protection, absorption, moisture-management design Expanding physical performance into a treatment effect
What contacts the body? Materials and ingredients by layer Treating backing and contact layers as one material
How long is exposure? Replacement, overall use, repeated application Counting one dressing but missing cumulative exposure

An unresolved cell is classification uncertainty. Do not fill it with the class of a visually similar product. When using a comparator, document differences in purpose, material, action and contact.

3. Separate claims from measured facts

An absorption or moisture-related result does not directly establish a shorter wound-healing period. An antimicrobial ingredient or laboratory result also does not automatically support infection treatment. Distinguish what was measured under stated conditions from what is claimed for patients.

Build a claim register linking sales wording, intended use, supporting evidence and unsupported scope. Missing evidence leads to further substantiation or a revised claim. The product listing advertising guide supports wording review after evidence and registration scope have been established.

4. Assess contact by layer and in the finished state

For multilayer products, distinguish possible direct and indirect contact from films, foam, adhesives and coatings. A shared material name does not establish identical additives or process residues. Describe the finished product after manufacturing, cleaning and sterilization as it contacts the body.

Do not simplify wound contact into intact-skin contact. Adhesive on surrounding skin can have a different contact condition from the wound-facing layer. Align duration and repeated use with the instructions and pass those inputs into biological evaluation. Actual risks and applicable Korean criteria determine the evaluation and testing needed.

5. Connect sterilization, packaging and shelf life

Consider whether absorption and adhesion remain supported after storage. Check that shelf-life evidence represents the actual material, size, sterilization and packaging combination. Evidence from a different package needs a justified bridge.

A larger model may change more than area: review sterilization, packaging space, folding and adhesive structure. This does not mean every change needs identical additional tests. Separate affected and unaffected attributes and document what existing evidence can support.

6. Feed classification decisions into test orders

A useful review record includes product description, candidate categories and reasoning, resolved and unresolved questions, and the evidence list by claim. Before ordering tests, reconcile intended use, contact and finished-product condition across specifications and instructions. Ordering a test bundle while classification remains uncertain can force later changes in samples or scope.

Bring a cross-section, layer materials, instructions and proposed claims to request a wound dressing classification review. Clare Partners can organize the questions and evidence sequence needed for the assessment.

Official references: MFDS integrated wound dressing approval and review guidance · Korean medical device review regulation. Checked 2026-09-28. Tables are practical recommendations and do not determine the classification of a particular product.

Frequently asked questions

Q. Are all hydrogel dressings in the same class?
Do not decide from material names alone. Compare the applicable item definition with intended use, wound type, composition, action and contact conditions.
Q. Does an antimicrobial test allow an infection-treatment claim?
Performance under test conditions and a clinical treatment claim are different. Assess the evidence and registration scope needed for the proposed purpose separately.
Q. Can it be evaluated as intact-skin contact?
Actual contact with wounds or damaged surfaces must be reflected. Distinguish contact with surrounding intact skin from the wound-contacting portion.

Just send the product details.
We do the reviewing.

We pre-review device class, required pathway, and data readiness free of charge, and reply within 1 business day. No sign-up.